PureTech Health plc
PRTC.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £402 | £507 | £623 | £669 |
| - Cash | £261 | £281 | £308 | £191 |
| + Debt | £21 | £159 | £145 | £136 |
| Enterprise Value | £162 | £385 | £459 | £613 |
| Revenue | £2 | £4 | £0 | £0 |
| % Growth | -54% | 1,298.3% | 60% | – |
| Gross Profit | -£23 | £43 | -£39 | -£43 |
| % Margin | -1,245.2% | 1,066.7% | -13,416.7% | -23,838.3% |
| EBITDA | -£46 | £102 | -£65 | -£69 |
| % Margin | -2,498.1% | 2,532.1% | -22,425% | -38,089.4% |
| Net Income | -£45 | £95 | -£42 | -£41 |
| % Margin | -2,409.8% | 2,366.1% | -14,504.5% | -22,607.2% |
| EPS Diluted | -0.19 | 0.35 | -0.15 | -0.15 |
| % Growth | -154.3% | 333.3% | 0% | – |
| Operating Cash Flow | -£46 | -£54 | -£80 | -£41 |
| Capital Expenditures | £0 | -£0 | £0 | £0 |
| Free Cash Flow | -£46 | -£54 | -£80 | -£41 |